Patent №
US 6,645,142
Granted
2003-11-11
Filed 2000
Owner
OPTISCAN BIOMEDICAL CORPORATION
Lab
—
AI components
1
evo
Assignment
Recorded
Dataset
AIPD
2023_r1 edition
Application
09728743
A glucose monitoring instrument having network-based communication features which provide a link between patient and practitioner. The glucose monitoring instrument comprises circuitry for communicating data with one or more destination sites on the network which are configured to transmit and receive information to and from the instrument. Instrument measurements are transmitted over the link in addition to information and guidance, to provide increased accuracy, improved program compliance, and patient guidance from a supervisory authority or medical practitioner. In addition, a set of calibration features encourage calibration compliance.
AI classification
Ownership
OPTISCAN BIOMEDICAL CORPORATION
assignment · 113360324
Assignors
BRAIG, JAMES R., HEWETT, GARY E., MUNROW, MICHAEL A., CORTELLA, JULIAN M., AZIZI, KAMRAVA, GOLDBERGER, DANIEL S.
On an employer assignment, the assignors are typically the inventors.